Le cout du diabete de type 2: resume de l'enquete europeenne CODE-2 et analyse de la situation en Belgique. ; The cost of type 2 diabetes: summary of the Cost of Diabetes in Europe-Type II study (CODE-2) and analysis of the situation in Belgium

peer reviewed ; Type 2 diabetes mellitus is a common chronic disease whose economic impact on both patients and society is constantly increasing. "The Cost of Diabetes in Europe--Type 2 study" is the first coordinated attempt to measure total healthcare costs of type 2 diabetes mellitus in Europe. On average, 3% of the population with type 2 diabetes accounted for 5% of the total healthcare expenditure. Complications have a substantial impact on the costs of managing type 2 diabetes. The prevention of complications, especially cardiovascular disease, will potentially reduce overall healthcare... Mehr ...

Verfasser: Wallemacq, Caroline
Van Gaal, L. F.
Scheen, André
Dokumenttyp: journal article
Erscheinungsdatum: 2005
Verlag/Hrsg.: Université de Liège. Revue Médicale de Liège
Schlagwörter: Belgium / Diabetes Complications/economics / Diabetes Mellitus / Type 2/economics / Europe / Health Care Costs/statistics & numerical data / Health Expenditures/statistics & numerical data / Humans / Human health sciences / Endocrinology / metabolism & nutrition / Sciences de la santé humaine / Endocrinologie / métabolisme & nutrition
Sprache: Französisch
Permalink: https://search.fid-benelux.de/Record/base-27363431
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://orbi.uliege.be/handle/2268/10252

peer reviewed ; Type 2 diabetes mellitus is a common chronic disease whose economic impact on both patients and society is constantly increasing. "The Cost of Diabetes in Europe--Type 2 study" is the first coordinated attempt to measure total healthcare costs of type 2 diabetes mellitus in Europe. On average, 3% of the population with type 2 diabetes accounted for 5% of the total healthcare expenditure. Complications have a substantial impact on the costs of managing type 2 diabetes. The prevention of complications, especially cardiovascular disease, will potentially reduce overall healthcare expenditure.